Welcome to LookChem.com Sign In|Join Free

CAS

  • or

190792-70-2

Post Buying Request

190792-70-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

190792-70-2 Usage

Description

3-Furanol,4-aminotetrahydro-,(3R,4S)-(9CI) is a specific type of chemical compound characterized by a furan-based structure, which is a heterocyclic organic ring compound. It is classified as an amino alcohol due to the presence of both an amino group (-NH2) and a hydroxy group (-OH). 3-Furanol,4-aminotetrahydro-,(3R,4S)-(9CI) is a derivative of tetrahydrofuran, indicating a saturated four-membered ring structure. The (3R,4S) configuration denotes the stereoisomer form of the compound, which signifies that it can exist in multiple forms that are mirror images of each other, akin to left and right hands. The term (9CI) refers to the Chemical Abstracts Service index name for the compound. The specific characteristics and applications of this compound are highly dependent on its unique structure and can vary across different scientific fields, such as pharmaceuticals or organic synthesis.

Uses

Used in Pharmaceutical Industry:
3-Furanol,4-aminotetrahydro-,(3R,4S)-(9CI) is used as an intermediate in the synthesis of various pharmaceutical compounds for its unique structural properties and reactivity. Its ability to form hydrogen bonds and its compatibility with other functional groups make it a valuable component in the development of new drugs.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Furanol,4-aminotetrahydro-,(3R,4S)-(9CI) serves as a versatile building block for the creation of complex organic molecules. Its presence of both amino and hydroxy groups allows for a wide range of chemical reactions, facilitating the synthesis of target molecules with specific properties and functions.
Used in Research and Development:
3-Furanol,4-aminotetrahydro-,(3R,4S)-(9CI) is utilized in research and development for its potential applications in various scientific areas. Its unique stereochemistry and reactivity make it an interesting subject for studying the effects of stereoisomerism on chemical behavior and biological activity. Additionally, it can be used to explore new reaction pathways and develop innovative synthetic methods.

Check Digit Verification of cas no

The CAS Registry Mumber 190792-70-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,7,9 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 190792-70:
(8*1)+(7*9)+(6*0)+(5*7)+(4*9)+(3*2)+(2*7)+(1*0)=162
162 % 10 = 2
So 190792-70-2 is a valid CAS Registry Number.

190792-70-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name trans-4-amino-3-hydroxytetrahydrofuran

1.2 Other means of identification

Product number -
Other names 3-Furanol,4-aminotetrahydro-,(3R,4S)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:190792-70-2 SDS

190792-70-2Relevant articles and documents

FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

-

Paragraph 0380-0382, (2019/10/10)

Provided are a class of compounds as shown in formula (I) as FGFR4 inhibitors, and pharmaceutically acceptable salts thereof, preparation methods therefor and the use thereof in the preparation of drugs for treating FGFR4-related diseases.

HETEROARYL COMPOUNDS AND USES THEREOF

-

Paragraph 00731, (2014/09/29)

The present invention relates to compounds useful as inhibitors of protein kinases, containing a cysteine residue in the ATP binding site. The invention further provides for pharmaceutically acceptable compositions comprising therapeutically effective amounts of one or more of the protein kinase inhibitor compounds and methods of using said compositions in the treatment of cancers and carcinomas.

Diastereoselective synthesis, activity and chiral stability of cyclic alkoxyketone inhibitors of cathepsin K

Fenwick, Ashley E.,Gribble, Andrew D.,Ife, Robert J.,Stevens, Nichola,Witherington, Jason

, p. 199 - 202 (2007/10/03)

The diastereoselective synthesis of a novel class of cathepsin K inhibitors together with their cathepsin K affinity and stability towards aqueous buffer is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 190792-70-2